Can Lyell Immunopharma Inc (LYEL) Stock Rise to the Top of Healthcare Sector Wednesday?

The 30 rating InvestorsObserver gives to Lyell Immunopharma Inc (LYEL) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 74 percent of stocks in the Healthcare sector, LYEL’s 30 overall rating means the stock scores better than 30 of all stocks.

LYEL has an Overall Score of 30. Find out what this means to you and get the rest of the rankings on LYEL!

See Full LYEL Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Lyell Immunopharma Inc Stock Today?

Lyell Immunopharma Inc (LYEL) stock has risen 9.07% while the S&P 500 is lower by -0.01% as of 1:42 PM on Wednesday, Mar 13. LYEL is up $0.20 from the previous closing price of $2.18 on volume of 459,747 shares. Over the past year the S&P 500 is higher by 32.04% while LYEL is up 1.28%. LYEL lost -$0.93 per share the over the last 12 months. Click Here to get the full Stock Report for Lyell Immunopharma Inc stock.